{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:23:31Z","timestamp":1774463011056,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00213-017-4738-y","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T06:51:01Z","timestamp":1505717461000},"page":"3507-3520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL\/6 mice"],"prefix":"10.1007","volume":"234","author":[{"given":"Timothy J.","family":"Donahue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Hillhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin A.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseu O.","family":"De Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"issue":"1","key":"4738_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","volume":"205","author":"AI Abbas","year":"2009","unstructured":"Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009) Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology 205(1):119\u2013128","journal-title":"Psychopharmacology"},{"key":"4738_CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(93)90267-L","volume":"237","author":"MB Assi\u00e9","year":"1993","unstructured":"Assi\u00e9 MB, Sleight AJ, Koek W (1993) Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics. Eur J Pharmacol 237:183\u2013189","journal-title":"Eur J Pharmacol"},{"key":"4738_CR3","doi-asserted-by":"crossref","first-page":"8.5F.1","DOI":"10.1002\/0471142301.ns0805fs25","volume":"25","author":"JE Barrett","year":"2003","unstructured":"Barrett JE, Vanover KE (2003) Assessment of learning and memory using the autoshaping of operant responding in mice. Current Protocols in Neuroscience 25:8.5F.1\u20138.5F.8","journal-title":"Current Protocols in Neuroscience"},{"key":"4738_CR4","unstructured":"Bianchetti G, Canal M, Rosenzweig P (1995) Amisulpride: summary of human pharmacology and pharmacokinetics. Report no. 95-00679-EN-02. Le Plessis Robinson: Synth\u00e8labo Groupe"},{"key":"4738_CR5","first-page":"1301","volume":"45","author":"P Borenstein","year":"1969","unstructured":"Borenstein P, Champion C, Cujo P, Geki\u00e8re F, Olivenstein C, Kramarz P (1969) An original psychotropic drug: sulpiride] Article in French. Sem Hop 45:1301\u20131314","journal-title":"Sem Hop"},{"key":"4738_CR6","volume-title":"Statistics in biology","author":"CI Bliss","year":"1967","unstructured":"Bliss CI (1967) Statistics in biology. McGraw-Hill, New York"},{"issue":"3","key":"4738_CR7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0022-5347(25)00190-9","volume":"241","author":"CL Boyajian","year":"1987","unstructured":"Boyajian CL, Leslie FM (1987) Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain. J Pharmacol Exp Ther 241(3):1092\u20131098","journal-title":"J Pharmacol Exp Ther"},{"key":"4738_CR8","doi-asserted-by":"crossref","unstructured":"Boyer P, Lecrubier Y (1996) Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine. European Psychiatry, Volume 11, Supplement 3, 1996, 135s\u2013140s","DOI":"10.1016\/0924-9338(96)85188-1"},{"issue":"3","key":"4738_CR9","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","volume":"315","author":"ES Burstein","year":"2005","unstructured":"Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR (2005) Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist. J Pharmacol Exp Ther 315(3):1278\u20131287","journal-title":"J Pharmacol Exp Ther"},{"issue":"2\u20133","key":"4738_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(01)01484-4","volume":"432","author":"MP Castelli","year":"2001","unstructured":"Castelli MP, Mocci I, Sanna AM, Gessa GL, Pani L (2001) (-)S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors. Eur J Pharmacol 432(2\u20133):143\u2013147","journal-title":"Eur J Pharmacol"},{"key":"4738_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.2042-7158.1988.tb06306.x","volume":"40","author":"JK Chivers","year":"1988","unstructured":"Chivers JK, Gommeren W, Leysen JE, Jenner P, Marsden CD (1988) Comparison of the in vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. J Pharm Pharmacol 40:415\u2013421","journal-title":"J Pharm Pharmacol"},{"key":"4738_CR12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0022-3565(24)37047-8","volume":"283","author":"C Cohen","year":"1997","unstructured":"Cohen C, Sanger DJ, Perrault G (1997) Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride. J Pharmacol Exp Ther 283:566\u2013573","journal-title":"J Pharmacol Exp Ther"},{"key":"4738_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2014.02.014","volume":"729","author":"GT Collins","year":"2014","unstructured":"Collins GT, Jackson JA, Koek W, France CP (2014) Effects of dopamine D2-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition. Eur J Pharmacol 729:123\u2013131","journal-title":"Eur J Pharmacol"},{"key":"4738_CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00023210-199606030-00006","volume":"6","author":"AJ Coukell","year":"1996","unstructured":"Coukell AJ, Spencer CM, Benfield L (1996) Amisulpride: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia. CNS Drugs 6:237\u2013256","journal-title":"CNS Drugs"},{"key":"4738_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2007-1014494","volume":"23","author":"A Delcker","year":"1990","unstructured":"Delcker A, Schoon ML, Oczkowski B, Gaertner HJ (1990) Amisulpride versus haloperidol in treatment of schizophrenic patients\u2014results of a double-blind study. Pharmacopsychiatry 23:125\u2013130","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"4738_CR16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/revneuro-2014-0009","volume":"25","author":"P DiPilato","year":"2014","unstructured":"DiPilato P, Niso M, Adriani W, Romano E, Travaglini D, Berardi F, Colabufo NA, Perrone R, Laviola G, Lacivita E, Leopoldo M (2014) Selective agonists for serotonin 7(5HT7) receptor and their applications in preclinical models: an overview. Rev Neurosci 25(3):401\u2013415","journal-title":"Rev Neurosci"},{"key":"4738_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2014.03.047","volume":"734","author":"TJ Donahue","year":"2014","unstructured":"Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH (2014) (S)-amisulpride as a discriminative stimulus in C57BL\/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics. Eur J Pharmacol 734:15\u201322","journal-title":"Eur J Pharmacol"},{"key":"4738_CR18","first-page":"298","volume":"3","author":"A Dufour","year":"1988","unstructured":"Dufour A, Desanti C (1988) Pharmacokinetics and metabolism of amisulpride. Ann Clin Psychiatry 3:298\u2013305","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"4738_CR19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00426467","volume":"73","author":"K Extance","year":"1981","unstructured":"Extance K, Goudie AJ (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73(4):363\u2013371","journal-title":"Psychopharmacology"},{"key":"4738_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(91)90294-Z","volume":"202","author":"LJ Furmidge","year":"1991","unstructured":"Furmidge LJ, Exner M, Clark D (1991) Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue. Eur J Pharmacol 202:191\u2013199","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4738_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FBP.0b013e3282f62d8c","volume":"19","author":"R Galici","year":"2008","unstructured":"Galici R, Boggs JD, Miller KL, Bonaventure P, Atack JR (2008) Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. Behav Pharmacol 19(2):153\u2013159","journal-title":"Behav Pharmacol"},{"key":"4738_CR22","volume-title":"Biostatistics: an introductory text","author":"A Goldstein","year":"1964","unstructured":"Goldstein A (1964) Biostatistics: an introductory text. McMillian Company, New York"},{"key":"4738_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00213-003-1576-x","volume":"171","author":"AJ Goudie","year":"2004","unstructured":"Goudie AJ, Smith BJ, Millan MJ (2004) Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine. Psychopharmacology 171:212\u2013222","journal-title":"Psychopharmacology"},{"key":"4738_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-3057(99)00079-9","volume":"64","author":"AJ Goudie","year":"1999","unstructured":"Goudie AJ, Smith JA (1999) Discriminative stimulus properties of antipsychotics. Pharmacol Biochem Behav 64:193\u2013201","journal-title":"Pharmacol Biochem Behav"},{"key":"4738_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s002130050527","volume":"135","author":"A Goudie","year":"1998","unstructured":"Goudie A, Taylor A (1998) Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology 135:392\u2013400","journal-title":"Psychopharmacology"},{"key":"4738_CR26","doi-asserted-by":"crossref","unstructured":"Hall H, S\u00e4llemark M, Jerning E (1986) Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. Acta Pharmacol Toxicol (Copenh) 58(1):61\u201370","DOI":"10.1111\/j.1600-0773.1986.tb00071.x"},{"key":"4738_CR27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-3565(25)10336-4","volume":"263","author":"EM Hoenicke","year":"1992","unstructured":"Hoenicke EM, Vanecek SA, Woods JH (1992) The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. J Pharmacol Exp Ther 263:276\u2013284","journal-title":"J Pharmacol Exp Ther"},{"key":"4738_CR28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0024-3205(79)90559-9","volume":"25","author":"P Jenner","year":"1979","unstructured":"Jenner P, Marsden CD (1979) The substituted benzamides\u2014a novel class of dopamine antagonists. Life Sci 25:479\u2013485","journal-title":"Life Sci"},{"issue":"3","key":"4738_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/syn.890150302","volume":"15","author":"RM Kessler","year":"1993","unstructured":"Kessler RM, Votaw JR, de Paulis T, Bingham DR, Ansari MS, Mason NS, Holburn G, Schmidt DE, Votaw DB, Manning RG et al (1993 Nov) (1993) Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors. Synapse 15(3):169\u2013176","journal-title":"Synapse"},{"issue":"2","key":"4738_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(96)00103-6","volume":"43","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Boyer P, Turjanski S, Rein W (1997) Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. J Affect Disord 43(2):95\u2013103","journal-title":"J Affect Disord"},{"key":"4738_CR31","first-page":"5895","volume":"23","author":"SE Leff","year":"1984","unstructured":"Leff SE, Chen A, Creese I (1984) Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS. Neuropharmacology 23:5895\u20135890","journal-title":"Neuropharmacology"},{"key":"4738_CR32","doi-asserted-by":"crossref","unstructured":"Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272(5649):168\u2013171","DOI":"10.1038\/272168a0"},{"key":"4738_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(02)01602-3","volume":"444","author":"G Marchese","year":"2002","unstructured":"Marchese G, Bartholini F, Ruiu S, Casti P, Saba P, Gessa G, Pani L (2002a) Effect of the amisulpride isomers on rat catalepsy. Eur J Pharmacol 444:69\u201374","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"4738_CR34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(02)01602-3","volume":"444","author":"G Marchese","year":"2002","unstructured":"Marchese G, Bartholini F, Ruiu S, Casti P, Saba P, Gessa G, Pani L (2002b) Effect of the amisulpride isomers on rat catalepsy. Eur J Pharmacol 444(1\u20132):69\u201374","journal-title":"Eur J Pharmacol"},{"key":"4738_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ddr.430180106","volume":"18","author":"JF McElroy","year":"1989","unstructured":"McElroy JF, Stimmel JJ, O\u2019Donnell JM (1989) Discriminative stimulus properties of haloperidol. Drug Dev Res 18:47\u201355","journal-title":"Drug Dev Res"},{"issue":"1\u20132","key":"4738_CR36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2005.07.049","volume":"1057","author":"K Morita","year":"2005","unstructured":"Morita K, Hamamoto M, Arai S, Kitayama S, Irifune M, Kawahara M, Kihira K, Dohi T (2005) Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities. Brain Res 1057(1\u20132):153\u2013160","journal-title":"Brain Res"},{"key":"4738_CR37","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","unstructured":"National Research Council (2011) Guide for the care and use of laboratory animals, Eight edn. National Academies, Washington D.C.","edition":"Eight"},{"key":"4738_CR38","unstructured":"Nelson DR, Thomas DR (1989) [3H]-BRL 43694 (granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes. Biochem Pharmacol May 15;38(10): 1693\u20131695"},{"issue":"6","key":"4738_CR39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00023210-199912060-00005","volume":"12","author":"S Noble","year":"1999","unstructured":"Noble S, Benfield P (1999) Amisulpride: a review of its clinical potential in dysthymia. CNS Drugs 12(6):471\u2013483","journal-title":"CNS Drugs"},{"key":"4738_CR40","unstructured":"Peroutka SJ, Hamik A (1988) [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes. Eur J Pharmacol 148(2):297\u2013299"},{"issue":"1","key":"4738_CR41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)36394-3","volume":"280","author":"G Perrault","year":"1997","unstructured":"Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B (1997) Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity. J Exp Ther 280(1):73\u201382","journal-title":"J Exp Ther"},{"issue":"1","key":"4738_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00213-005-2147-0","volume":"180","author":"SD Philibin","year":"2005","unstructured":"Philibin SD, Prus AJ, Pehrson AL, Porter JH (2005) Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL\/6 mice. Psychopharmacology (Berl) 180(1):49\u201356","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"4738_CR43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-008-1385-3","volume":"203","author":"SD Philibin","year":"2009","unstructured":"Philibin SD, Walentiny DM, Vunck SA, Prus AJ, Meltzer HY, Porter JH (2009) Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL\/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism. Psychopharmacology (Berl) 203(2):303\u2013315","journal-title":"Psychopharmacology (Berl)"},{"key":"4738_CR44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-008-1308-3","volume":"203","author":"JH Porter","year":"2009","unstructured":"Porter JH, Prus AJ (2009) Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies. Psychopharmacology 203:279\u2013294","journal-title":"Psychopharmacology"},{"issue":"2","key":"4738_CR45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002139900366","volume":"149","author":"JH Porter","year":"2000","unstructured":"Porter JH, Varvel SA, Vann RE, Philibin SD, Wise LE (2000) Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology 149(2):189\u2013193","journal-title":"Psychopharmacology"},{"issue":"2","key":"4738_CR46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.fbp.0000197457.70774.91","volume":"17","author":"AJ Prus","year":"2006","unstructured":"Prus AJ, Philibin SD, Pehrson AL, Porter JH (2006) Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg\/kg clozapine vs. 5.0 mg\/kg clozapine vs. vehicle. Behav Pharmacol 17(2):185\u2013194","journal-title":"Behav Pharmacol"},{"issue":"3","key":"4738_CR47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0165-0327(01)00327-5","volume":"70","author":"P Rocca","year":"2002","unstructured":"Rocca P, Fonzo V, Ravizza L, Rocca G, Scotta M, Zanalda E, Bogetto F (2002) A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder. J Affect Disord 70(3):313\u2013317","journal-title":"J Affect Disord"},{"key":"4738_CR48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0922-4106(90)90230-U","volume":"189","author":"D Rognan","year":"1990","unstructured":"Rognan D, Sokoloff P, Mann A, Martres MP, Schwartz JC, Costentin J, Wermuth CG (1990) Optically active benzamides as predictive tools for mapping the dopamine D2 receptor. Eur J Pharmacol 189:59\u201370","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4738_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.320","volume":"17","author":"P Rosenzweig","year":"2002","unstructured":"Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G (2002) A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol 17(1):1\u201313","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"4738_CR50","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","volume":"268","author":"BL Roth","year":"1994","unstructured":"Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268(3):1403\u20131410","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"4738_CR51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/107385840000600408","volume":"6","author":"BL Roth","year":"2000","unstructured":"Roth BL, Lopez E, Patel S, Kroeze W (2000) The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches? Neuroscientist 6(4):252\u2013262","journal-title":"Neuroscientist"},{"key":"4738_CR52","doi-asserted-by":"crossref","unstructured":"Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC (1993) Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proceedings of the Academy of Sciences (USA) Sep 15;90(18): 8547-8551","DOI":"10.1073\/pnas.90.18.8547"},{"key":"4738_CR53","first-page":"292","volume":"154","author":"K Satoh","year":"1997","unstructured":"Satoh K, Someya T, Shibasaki M (1997) Nemonapride for the treatment of schizophrenia. Am J Psychiatry 154:292","journal-title":"Am J Psychiatry"},{"key":"4738_CR54","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0091-3057(83)90074-6","volume":"19","author":"MD Schechter","year":"1983","unstructured":"Schechter MD (1983) Discriminative stimulus control with imipramine: transfer to other anti-depressants. Pharmacol Biochem Behav 19:751\u2013754","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"4738_CR55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)36395-5","volume":"280","author":"H Schoemaker","year":"1997","unstructured":"Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997) Neurochemical characteristics of amisulpride, an atypical dopamine D2\/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280(1):83\u201397","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"4738_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0922-4106(95)90125-6","volume":"291","author":"P Seeman","year":"1995","unstructured":"Seeman P, Van Tol HHM (1995) Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand. Eur J Pharmacol 291(2):59\u201366","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4738_CR57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0893-133X(96)00187-X","volume":"16","author":"P Seeman","year":"1997","unstructured":"Seeman P, Corbett R, Van Tol HH (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16(2):93\u2013110","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"4738_CR58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1566-2772(00)00007-4","volume":"1","author":"P Seeman","year":"2001","unstructured":"Seeman P (2001) Antipsychotic drugs, dopamine receptors, and schizophrenia. Clinical Neuroscience Research 1(1\u20132):53\u201360","journal-title":"Clinical Neuroscience Research"},{"issue":"1\u20133","key":"4738_CR59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2013.10.036","volume":"720","author":"KL Shelton","year":"2013","unstructured":"Shelton KL, Nicholson KL (2013) Benzodiazepine-like discriminative stimulus effects of toluene vapor. Eur J Pharmacol 720(1\u20133):131\u2013137","journal-title":"Eur J Pharmacol"},{"issue":"24","key":"4738_CR60","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","volume":"268","author":"Y Shen","year":"1993","unstructured":"Shen Y, Monsma FJ Jr, Metcalf MA, Josef PA, Hamblin MW, Sibley DR (1993) Molecular cloning and expression of a 5-hydroxytryptamine 7 serotonin receptor subtype. J Biol Chem 268(24):18200\u201318204","journal-title":"J Biol Chem"},{"issue":"1","key":"4738_CR61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0327(97)00139-0","volume":"48","author":"E Smeraldi","year":"1998","unstructured":"Smeraldi E (1998) Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study. J Affect Disord 48(1):47\u201356","journal-title":"J Affect Disord"},{"issue":"4","key":"4738_CR62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1037\/1064-1297.10.4.376","volume":"10","author":"JA Smith","year":"2002","unstructured":"Smith JA, Goudie AJ (2002) Discriminative stimulus properties in rats of the novel antipsychotic quetiapine. Exp Clin Psychopharmacol 10(4):376\u2013384","journal-title":"Exp Clin Psychopharmacol"},{"key":"4738_CR63","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","volume":"347","author":"P Sokoloff","year":"1990","unstructured":"Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146\u2013151","journal-title":"Nature"},{"key":"4738_CR64","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1471-4159.1992.tb10993.x","volume":"59","author":"T Tanaka","year":"1992","unstructured":"Tanaka T, Vincent SR, Nomikos GG, Fibiger HC (1992) Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum. J Neurochem 59:1640\u20131645","journal-title":"J Neurochem"},{"key":"4738_CR65","unstructured":"Toll L, Berzetei-Gurske IP, Polgar WE, Brandt SR, Adapa ID, Rodriguez L, Schwartz RW, Haggart D, O\u2019Brien A, White A, Kennedy JM, Craymer K, Farrington L, Auh JS (1998) Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA Res Monogr 178:440\u2013466"},{"issue":"4","key":"4738_CR66","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0091-3057(93)90023-M","volume":"44","author":"M Ukai","year":"1993","unstructured":"Ukai M, Mori E, Kameyama T (1993) Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm. Pharmacol Biochem Behav 44(4):907\u2013911","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"4738_CR67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(98)00621-9","volume":"359","author":"N Upton","year":"1998","unstructured":"Upton N, Stean T, Middlemiss D, Blackburn T, Kennett G (1998) Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents. Eur J Pharmacol 359(1):33\u201340","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4738_CR68","first-page":"273","volume":"9","author":"K Vanover","year":"1998","unstructured":"Vanover K, Barrett J (1998) An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response. Behav Pharmacol 9(3):273\u2013283","journal-title":"Behav Pharmacol"},{"issue":"4","key":"4738_CR69","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0091-3057(91)90077-F","volume":"40","author":"R Young","year":"1991","unstructured":"Young R, Johnson DN (1991) Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light\/dark test. Pharmacol Biochem Behav 40(4):733\u2013737","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20133","key":"4738_CR70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(02)01554-6","volume":"443","author":"R Young","year":"2002","unstructured":"Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443(1\u20133):113\u2013118","journal-title":"Eur J Pharmacol"},{"key":"4738_CR71","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0022-3565(25)20482-7","volume":"259","author":"L Zhang","year":"1991","unstructured":"Zhang L, Barrett JE (1991) Imipramine as a discriminative stimulus. J Pharmacol Exp Ther 259:1088\u20131093","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4738-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4738-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4738-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:46:13Z","timestamp":1750880773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4738-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":71,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4738"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4738-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}